Search results
Innovation And Automation Are Driving Forces Behind Next Generation Cell Therapy Manufacturing...
EnterpriseContentManagementConnection-ECM· 6 days agoCytiva is tackling industry challenges that hinder patient access and wider adoption of autologous CAR T cell therapies with the new Sefia cell
Innovation And Automation Are Driving Forces Behind Next Generation Cell Therapy Manufacturing...
BioresearchOnline· 5 days agoCytiva is tackling industry challenges that hinder patient access and wider adoption of autologous...
Triplet Notches Survival Win in Heavily Pretreated DLBCL
MedPage Today· 2 days agoBenefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant
Small Business - Picayune Item | Picayune Item
The Picayune Item· 5 days agoAdaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next generation MAGE-A4 TCR T-cell ...
Chinese cell therapy may treat asthma long term with a single jab: study
South China Morning Post· 2 days agoIn their latest study, Peng’s team developed a new way to target this group of cytokines...
Two-pronged attack strategy boosts immunotherapy i | Newswise
Newswise· 1 day agoThe research focuses on an immunotherapy called adoptive cell transfer (ACT), which involves...
Cell therapy reckoning: How a 'remarkable resolution of lupus' carried CAR-T from cancer to...
FierceBiotech· 5 days agoIn a last-ditch attempt to salvage her poor prognosis, her care team at University Hospital Erlangen...
Scientists find 'Goldilocks' binding strength determines anti-cancer T-cell efficacy and fate
Medical Xpress· 5 days agoSt. Jude Children's Research Hospital scientists found that how tight a parental T cell grabs a cancer protein determines if its daughter cells will be ...
Factor Bioscience Successfully Defends Three U.S. Patents Covering Foundational Methods for...
KOLR - KSFX Ozarks· 7 days ago-Patented methods relate to multiple allogeneic CAR T-cell therapies under clinical development for the treatment of B-cell lymphoma, chronic lymphocytic ...
Scientists discover a novel modulator of human regulatory T cells
Medical Xpress· 5 days agoThe Lahesmaa group is based at Turku Bioscience Center of the University of Turku and Åbo Akademi University in Finland and is part of the InFLAMES Research Flagship. Specific regulatory T cells ...
